Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver

BACKGROUND: Many studies have investigated the progression of nonalcoholic fatty liver disease (NAFLD) and its predisposing risk factors, but the conclusions from these studies have been conflicting. More challenging is the fact that no effective treatment is currently available for NAFLD. AIM: To d...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafiq, Muhammad, Walmann, Timothy, Nutalapati, Venkat, Gibson, Cheryl, Zafar, Yousaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772734/
https://www.ncbi.nlm.nih.gov/pubmed/33442452
http://dx.doi.org/10.4254/wjh.v12.i12.1258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772734/
https://www.ncbi.nlm.nih.gov/pubmed/33442452
http://dx.doi.org/10.4254/wjh.v12.i12.1258

Ejemplares similares